A new study published in the journal JAMA Otolaryngology-Head & Neck Surgery published on Feb. 24, 2022 has found a possible association between Pfizer/BioNTech's BNT162b2 (also known as "Comirnaty") messenger RNA (mRNA) COVID-19 biologic and sudden sensorineural hearing loss (SSNHL). The...